The overexpression of Ascl2 attenuated colitis symptoms in mice by reducing inflammation and decreasing Th17 cell infiltration in Ascl2-overexpressing experimental colitis mouse models, revealing that Ascl2 is a potential therapeutic target for the treatment of colitis. The gene discussed is ASCL2; the disease is colitis.